Uncategorized
Parion Sciences initiates phase 2 trial of P-321 ophthalmic solution for dry eye disease
Patient enrollment is underway for a phase 2 clinical trial of P-321 ophthalmic solution for the treatment of dry eye disease, according to a press release from Parion Sciences.The study, P-321-202, will assess the impact of the ophthalmic solution on dry eye symptoms, as well as safety and clinical signs of dry eye.